R/Medicine 2026 is approaching, with keynotes on software sustainability, accountable algorithm design, and rigorous evaluation of generative AI.

Join keynote talks from Yanina Bellini Saibene, David Robinson, and Peter Gruber.

Register now: https://rconsortium.github.io/RMedicine_website/

#rstats #clinicaltrials #healthcare #opensource

@yabellini

Clinical trial: Benefits of a High-Intensity Exercise Program With Immersive Virtual Reality in Multiple Sclerosis: Exploratory Study

https://clinicaltrials.gov/study/NCT07543900?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20473

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Evaluation of the Effect of Quran Recitation on Fatigue and Mental Well-Being in MS Patients: A Randomized Controlled Trial

https://clinicaltrials.gov/study/NCT07544303?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20474

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Percutaneous Versus Transcutaneous Nerve Stimulation of the Median, Radial, and Ulnar Nerves: Effects on Hand Function in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07546318?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20475

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS).

https://clinicaltrials.gov/study/NCT07546110?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20476

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?

https://clinicaltrials.gov/study/NCT07545889?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20477

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC® Followed by Open-Label, Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

https://clinicaltrials.gov/study/NCT01994109?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_20464

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology